Corteva (NYSE:CTVA – Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 3.450-3.700 for the period, compared to the consensus earnings per share estimate of 3.230. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.4 billion.
Analyst Ratings Changes
A number of brokerages have commented on CTVA. Zacks Research upgraded shares of Corteva from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 22nd. Wall Street Zen raised Corteva from a “hold” rating to a “buy” rating in a research report on Saturday, January 17th. The Goldman Sachs Group upped their price target on Corteva from $77.00 to $78.00 and gave the stock a “buy” rating in a report on Tuesday, December 16th. Royal Bank Of Canada dropped their price objective on Corteva from $86.00 to $80.00 and set an “outperform” rating on the stock in a research note on Friday, October 17th. Finally, Oppenheimer upped their target price on shares of Corteva from $76.00 to $78.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 27th. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Corteva presently has an average rating of “Moderate Buy” and a consensus price target of $79.58.
Get Our Latest Research Report on CTVA
Corteva Trading Up 2.3%
Corteva (NYSE:CTVA – Get Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same period last year, the firm posted $0.32 EPS. The business’s revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts expect that Corteva will post 2.96 earnings per share for the current year.
Corteva Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 30.77%.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in CTVA. Sunbelt Securities Inc. lifted its position in shares of Corteva by 52.8% in the 3rd quarter. Sunbelt Securities Inc. now owns 923 shares of the company’s stock worth $62,000 after purchasing an additional 319 shares during the period. Coldstream Capital Management Inc. lifted its position in Corteva by 6.3% during the third quarter. Coldstream Capital Management Inc. now owns 14,967 shares of the company’s stock valued at $1,012,000 after buying an additional 892 shares during the period. Financial Engines Advisors L.L.C. bought a new stake in shares of Corteva during the 3rd quarter valued at $203,000. Palisade Asset Management LLC purchased a new stake in shares of Corteva in the 3rd quarter worth about $67,000. Finally, NewEdge Advisors LLC grew its position in shares of Corteva by 2.2% in the 3rd quarter. NewEdge Advisors LLC now owns 31,587 shares of the company’s stock worth $2,136,000 after buying an additional 695 shares during the period. 81.54% of the stock is owned by hedge funds and other institutional investors.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Stories
- Five stocks we like better than Corteva
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
